Oda; Tomoko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Oda; Tomoko.The latest application filed is for "lipoic acid prodrug".

Company Profile

6.7.18

Oda; Tomoko - Nara JP
ODA; Tomoko - Ikoma-shi Nara
Oda; Tomoko - Ikoma JP
ODA; Tomoko - lkoma-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ursodeoxycholic acid-containing agent for treating or preventing presbyopia Grant 11,419,880 - Kato , et al. August 23, 2	2022-08-23
Lipoic Acid Prodrug App 20220151989 - KATO; Masatomo ; et al.	2022-05-19
Ursodeoxycholic Acid-containing Agent For Treating Or Preventing Presbyopia App 20220096497 - KATO; Masatomo ; et al.	2022-03-31
Ursodeoxycholic Acid-containing Agent For Treating Or Preventing Presbyopia App 20220072012 - KATO; Masatomo ; et al.	2022-03-10
Agent Containing 4-phenylbutyrate, For Preventing Or Treating Presbyopia App 20220062209 - KATO; Masatomo ; et al.	2022-03-03
Method For Changing Condition Of Eyelid Of Hairless Animal App 20210011004 - MIYAKE; Hideki ; et al.	2021-01-14
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)phenoxy]ethyloxy Compound Or Salt Thereof App 20190359577 - KAWASHIMA; Kenji ; et al.	2019-11-28
[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof Grant 10,435,379 - Kawashima , et al. O	2019-10-08
Therapeutic Agent For Meibomian Dysfunction App 20190255026 - MIYAKE; Hideki ; et al.	2019-08-22
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)phenoxy]ethyloxy Compound Or Salt Thereof App 20190106393 - KAWASHIMA; Kenji ; et al.	2019-04-11
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof Grant 10,189,796 - Kawashima , et al. Ja	2019-01-29
Method for changing condition of an eyelid for evaluation of an eyelid disease involving plugging of meibomian gland orifices and/or telangiectasia by administration of complete freund's adjuvant Grant 10,143,761 - Miyake , et al. De	2018-12-04
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)phenoxy]ethyloxy Compound Or Salt Thereof App 20180244633 - KAWASHIMA; Kenji ; et al.	2018-08-30
Method For Changing Condition Of Eyelid Of Hairless Animal App 20180246081 - MIYAKE; Hideki ; et al.	2018-08-30
Therapeutic Agent For Meibomian Dysfunction App 20180021314 - MIYAKE; Hideki ; et al.	2018-01-25
Therapeutic Agent For Meibomian Gland Dysfunction App 20160022648 - MIYAKE; Hideki ; et al.	2016-01-28
Method For Changing Condition Of Eyelid By Administering Complete Freund's Adjuvant App 20150125395 - Miyake; Hideki ; et al.	2015-05-07
Method For Changing Condition Of Eyelid Of Hairless Animal App 20150125394 - Miyake; Hideki ; et al.	2015-05-07
Method for preventing or treating a glucocorticoid receptor-related disease Grant 8,420,635 - Matsuda , et al. April 16, 2	2013-04-16
Method for preventing or treating a glucocorticoid receptor-related disease App 20110263589 - Matsuda; Mamoru ; et al.	2011-10-27
1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity Grant 8,017,775 - Matsuda , et al. September 13, 2	2011-09-13
Novel 1-2-Dihydroquinoline Derivative Having Glucocorticoid Receptor Binding Activity App 20090326009 - Matsuda; Mamoru ; et al.	2009-12-31
Therapeutic Agent for Pruritus Comprising P38 Map Kinase Inhibitor as the Active Ingredient App 20080119498 - Kato; Masatomo ; et al.	2008-05-22
Remedy for pruritus comprising piperidine derivative as the active ingredient App 20060258703 - Shii; Daisuke ; et al.	2006-11-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.